RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-6.87%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.23B
AUM Growth
+$6.23B
Cap. Flow
+$768M
Cap. Flow %
12.33%
Top 10 Hldgs %
46.21%
Holding
101
New
19
Increased
9
Reduced
3
Closed
9

Top Buys

1
JANX icon
Janux Therapeutics
JANX
$216M
2
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$189M
3
DAWN icon
Day One Biopharmaceuticals
DAWN
$113M
4
LENZ
LENZ Therapeutics
LENZ
$82.9M
5
CNTB
Connect Biopharma
CNTB
$78.1M

Top Sells

1
NVAX icon
Novavax
NVAX
$93.9M
2
ADVM icon
Adverum Biotechnologies
ADVM
$92.3M
3
IGMS
IGM Biosciences
IGMS
$75.4M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
$52.4M
5
TGTX icon
TG Therapeutics
TGTX
$50.2M

Sector Composition

1 Healthcare 97.5%
2 Financials 0.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BOLT icon
51
Bolt Biotherapeutics
BOLT
$9.29M
$36.8M 0.59%
118,916
– –
INZY
52
DELISTED
Inozyme Pharma
INZY
$34.1M 0.55%
2,003,653
– –
VRNA
53
Verona Pharma
VRNA
$9.18B
$33.4M 0.54%
5,100,000
– –
BDTX icon
54
Black Diamond Therapeutics
BDTX
$164M
$31.6M 0.51%
2,589,904
– –
AKUS
55
DELISTED
Akouos, Inc. Common Stock
AKUS
$28.6M 0.46%
2,281,249
– –
CNTA
56
Centessa Pharmaceuticals
CNTA
$2.13B
$28.4M 0.46%
+1,280,300
New +$28.4M
IPSC icon
57
Century Therapeutics
IPSC
$40.4M
$26.8M 0.43%
+914,094
New +$26.8M
NAUT icon
58
Nautilus Biotechnolgy
NAUT
$80.7M
$25M 0.4%
2,471,430
+1,500,000
+154% +$15.1M
CTMX icon
59
CytomX Therapeutics
CTMX
$350M
$22.2M 0.36%
3,500,000
– –
SCPH icon
60
scPharmaceuticals
SCPH
$296M
$16.7M 0.27%
2,731,170
– –
LRMR icon
61
Larimar Therapeutics
LRMR
$337M
$14.9M 0.24%
1,515,151
– –
TNGX icon
62
Tango Therapeutics
TNGX
$745M
$14.2M 0.23%
1,250,000
– –
ENTX icon
63
Entera Bio
ENTX
$92.7M
$14.1M 0.23%
+2,353,000
New +$14.1M
BLSA
64
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$13.2M 0.21%
1,250,000
– –
CNCE
65
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$12.8M 0.21%
3,033,603
– –
ATXS icon
66
Astria Therapeutics
ATXS
$394M
$12.6M 0.2%
+991,310
New +$12.6M
MIST icon
67
Milestone Pharmaceuticals
MIST
$151M
$12.4M 0.2%
2,246,503
– –
PNT
68
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$11.3M 0.18%
+1,098,318
New +$11.3M
EYPT icon
69
EyePoint Pharmaceuticals
EYPT
$827M
$11.2M 0.18%
1,250,000
– –
ARYD
70
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$10.7M 0.17%
1,000,000
– –
OCUL icon
71
Ocular Therapeutix
OCUL
$2.25B
$10.6M 0.17%
750,000
– –
PHAS
72
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$10.6M 0.17%
2,850,000
– –
IMA
73
ImageneBio, Inc. Common Stock
IMA
$153M
$10.5M 0.17%
62,500
– –
ORIC icon
74
Oric Pharmaceuticals
ORIC
$1.03B
$10.3M 0.17%
584,000
– –
FLACU
75
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$10.1M 0.16%
1,000,000
– –
1 2
3
4 5